* Joint Corp JYNT.OQ reported a quarterly adjusted loss
of 13
cents per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of -1
cents. The mean expectation of five analysts for the quarter
was for a loss of 2 cents per share. Wall Street expected
results to range from -7 cents to 3 cents per share.
* Revenue rose 3.3% to $30.26 million from a year ago;
analysts
expected $29.40 million.
* Joint Corp's reported EPS for the quarter was a loss of 24
cents.
* The company reported a quarterly loss of $3.57 million.
* Joint Corp shares had fallen by 12.3% this quarter and
gained 28.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Joint Corp is
$15.50
This summary was machine generated from LSEG data August 9 at
06:08 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2024 -0.02 -0.13 Missed
Mar. 31 2024 -0.01 0.06 Beat
Dec. 31 2023 0.01 -0.75 Missed
Sep. 30 2023 0.02 -0.05 Missed